Skip to main content
Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
15.50
+0.04 (0.26%)
Dec 20, 2024, 4:00 PM EST - Market closed

Arcus Biosciences Revenue

Arcus Biosciences had revenue of $48.00M in the quarter ending September 30, 2024, with 50.00% growth. This brings the company's revenue in the last twelve months to $263.00M, up 119.17% year-over-year. In the year 2023, Arcus Biosciences had annual revenue of $117.00M with 4.46% growth.

Revenue (ttm)
$263.00M
Revenue Growth
+119.17%
P/S Ratio
5.07
Revenue / Employee
$455,806
Employees
577
Market Cap
1.42B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023117.00M5.00M4.46%
Dec 31, 2022112.00M-271.00M-70.76%
Dec 31, 2021383.00M305.00M391.03%
Dec 31, 202078.00M63.00M420.00%
Dec 31, 201915.00M6.65M79.58%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Indivior 1.18B
Novavax 885.19M
InMode 423.75M
Phreesia 405.14M
Kiniksa Pharmaceuticals International, 384.10M
Immunocore Holdings 296.31M
Schrödinger 193.35M
Nurix Therapeutics 56.42M
Revenue Rankings

RCUS News

More News